Immuno Oncology Assays Market Set to Grow at 12.7% CAGR and Projected to Reach USD 5.9 billion by 2024 Dominated by Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US) Top Players

Download Free PDF Brochure of Immuno Oncology Assays Market Research at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1943305 .

The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. However, the high cost of immuno therapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.

Immuno Oncology Assays Market Report by Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing Technologies and Lung Cancer, Colorectal Cancer Applications to 2023. Immuno Oncology Assays Market Study Highlights the Regions like Asia, Pacifics and North America. The study also includes an in-depth competitive analysis of the key players in the market.

Competitive Landscape
1 Overview
2 Vendor Benchmarking
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Dynamic Differentiators
7 Emerging Companies
8 Market Ranking Analysis, 2017
9 Competitive Situation and Trends
10 Collaborations
11 Product Launches
12 Acquisitions
13 Expansions

The immuno-oncology assays market is segmented into consumables and software. The consumables segment dominated the market with the largest share in 2018; this segment is also expected to register the highest CAGR during the forecast period. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, increasing use of reagents in different oncology therapeutic treatments, increasing research on cancer immunotherapy biomarkers and its applications in drug development, and easy accessibility to a wide range of reagents.

More Information Now on The Immuno-Oncology Assays Market Report Now at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1943305 .

The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs.

The immuno-oncology assays market is segmented into research applications and clinical diagnostics. Research applications dominated the market with the largest share in 2018. It is also projected to be the fastest-growing segment during the forecast period. The rising prominence of biomarker-based drug development and clinical trials and the emergence of cancer immunotherapy are the key factors driving market growth.

Key organizations operating in the immuno-oncology assays market.
• By Company Type: Tier 1:18%, Tier 2: 39%, and Tier 3: 43%
• By Designation: C-level Executives: 25%, Directors: 20%, and Others:55%
• By Region: North America: 40%, Europe: 27%, APAC: 20%, and RoW: 13%

The immuno-oncology assays market is divided into four major regions— North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies are some factors supporting the growth of this region.

Order the “Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024” report at https://www.reportsnreports.com/purchase.aspx?name=1943305 .

The immuno-oncology assays market comprises major providers such as Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). The study includes an in-depth competitive analysis of these key players in the immuno-oncology assays market, along with their company profiles, recent developments, and key market strategies.

Asia Pacific is projected to record Immuno Oncology Assays Market report highest growth rate during the forecast period. Factors such as growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.